Crigler-Najjar syndrome: Gene therapy maintains its efficacy four years after treatment
The New England Journal of Medicine has published a study on the long-term efficacy of AAV8-mediated gene therapy (GNT0003) in patients with Crigler-Najjar syndrome, an extremely rare congenital liver disorder affecting approximately ...
Nov 6, 2026
0
12

